Akoya Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021

MENLO PARK, Calif.--(BUSINESS WIRE)--Akoya Biosciences, Inc., The Spatial Biology Company®, today announced that Brian McKelligon, the company’s Chief Executive Officer, is scheduled to present at the J.P. Morgan 39^th Annual Healthcare Conference on Wednesday, January 13, 2021. Mr. McKelligon will provide a company overview of Akoya and its spatial phenotyping solutions.

About Akoya Biosciences

Akoya Biosciences, The Spatial Biology Company™, offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. The company has two industry-leading platforms that empower investigators and researchers to gain a deeper understanding of complex diseases such as cancer, and other immune system or neurological disorders. The CODEX® system is the only benchtop platform that can efficiently quantify more than 40 biomarkers and is ideally suited for biomarker discovery. The Phenoptics™ platform is the only end-to-end multiplexed immunofluorescence solution with the robustness and high throughput necessary for translational research and clinical trials. For more information, please visit https://www.akoyabio.com/.